Working… Menu

Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03379259
Recruitment Status : Terminated (Study Was Terminated Early)
First Posted : December 20, 2017
Last Update Posted : May 10, 2021
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 8, 2020
Actual Study Completion Date : September 8, 2020
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 September 3, 2021